Table 5.
Socioeconomic differences in the utilization of antimalarials by pregnant women
| Antimalarials used for treatment of fever | Q1 (%) | Q2 (%) | Q3 (%) | Q4 (%) | Q5 (%) | Q1:Q5 | Chi square (p value) |
|---|---|---|---|---|---|---|---|
|
Children less than five years |
|
|
|
|
|
|
|
| ACTs |
9(28) |
13(29) |
13(33) |
29(43) |
27(26) |
1.1 |
5.97(0.20) |
| Chloroquine |
0(0) |
1(2) |
0(0) |
0(0) |
2(2) |
0 |
2.85(0.58) |
| Quinine |
0(0) |
0(0) |
1(2.6) |
1(1.5) |
1(1) |
0 |
1.83(0.77) |
| Sulfadoxine-pyrimethamine |
7(21) |
11(24) |
8(21) |
13(19) |
22(21) |
1 |
0.42(0.98) |
| Artesunate monotherapy |
1(3) |
2(4) |
5(13) |
4(6) |
9(9) |
0.3 |
3.69(0.45) |
| Others |
5(15) |
4(9) |
7(18) |
7(10) |
6(6) |
2.5 |
5.61(0.23) |
|
Pregnant women for treatment of malaria |
|
|
|
|
|
|
|
| ACTs |
10(27) |
16(28) |
15(34) |
36(48) |
42(38) |
0.71 |
7.66(0.11) |
| Chloroquine |
0(0) |
0(0) |
0(0) |
0(0) |
1(1) |
0.0 |
1.94(0.75) |
| Quinine |
1(3) |
0(0) |
1(2.3) |
1(1.3) |
2(2) |
1.49 |
1.45(0.84) |
| Sulfadoxine-pyrimethamine |
10(27) |
21(37) |
14(32) |
16(21) |
30(27) |
0.99 |
4.21(0.38) |
| Artesunate monotherapy |
0(0) |
1(2) |
0(0) |
1(1) |
1(1) |
0.0 |
1.32(0.86) |
| Others | 10(27) | 5(9) | 11(25) | 12(16) | 6(5) | 4.95 | 18.09(0.001) |